We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BHVN market cap is 3.74B. The company's latest EPS is USD -4.0364 and P/E is -8.98.
Quarter End | ||
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -567.93M | -436.05M |
Net Income | -570.28M | -408.17M |
Quarter End | ||
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 661.78M | 513.21M |
Total Liabilities | 123.01M | 85.24M |
Total Equity | 538.77M | 427.98M |
Market Cap | 3.74B |
Price to Earnings Ratio | -8.98 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 14.75 |
Price to Book Ratio | 8.56 |
Dividend Yield | - |
Shares Outstanding | 101.12M |
Average Volume (1 week) | 1.3M |
Average Volume (1 Month) | 1.04M |
52 Week Change | -14.64% |
52 Week High | 62.21 |
52 Week Low | 26.80 |
Spread (Intraday) | 0.05 (0.14%) |
Company Name | Biohaven Ltd |
Address |
p.o. box 173 road town, tortola |
Website | https://www.biohavenpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions